Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Shionogi: an expanding commercial focus

PMLiVE’s new emerging companies series starts with a Japanese firm that’s increasing its European footprint

Pharma Comes Out of the Branding Dark Ages

Isn't it high time that the pharma industry takes branding seriously rather than leaving it purely to their portfolio powerhouses?

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

New data backs Pfizer’s Eliquis in atrial fibrillation

Findings bode well for the drug's commercial prospects

- PMLiVE

Clear Channel UK teams up with men’s health charity Movember

The agency will use its digital advertising network to drive awareness of men’s health

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

Icon boosts Asia Pacific and Latin American leadership

Appoints Wei Ming Goh and Dr Dennis Hurley as regional VPs

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

EC pricing and reimbursement efficiency plans

The European Commission (EC) is working to help medicines reach the market quicker by streamlining the pricing and reimbursement process

- PMLiVE

NICE in U-turn on Novartis’ Lucentis in diabetic macular oedema

Patient access scheme influences draft recommendation

- PMLiVE

The evolving landscape of medical education, part three

Who are we trying to educate?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links